But not to get too serious and to join in the fun, here is my contribution to the discussion:
According to further research, Borderline Personality Disorder has a strong correlation with elevated midichlorian levels. GalacticSmithKline has been racing Pfazer for the first patented pharmaceutical that will effectively lower midichlorian levels. In trial studies, side effects include dry mouth, fatigue, irritability, insomnia, and lowered telekinesis.